‘Nonspecific’ MHC-unrestricted killer cells and their receptors
Identifieur interne : 002285 ( Main/Curation ); précédent : 002284; suivant : 002286‘Nonspecific’ MHC-unrestricted killer cells and their receptors
Auteurs : Peter Hersey [Australie] ; Reinder Bolhuis [Pays-Bas]Source :
- Immunology Today [ 0167-5699 ] ; 1987.
English descriptors
- Teeft :
- Aiio, Autol, Autol aiio, Autologous tumour cells, Bolhuis, Cell growth, Cell surface, Clone, Conjugate formation, Cytotoxic, Cytotoxic activity, Cytotoxicity, Determinant, Effector, Effector cells, Etal, Griend, Immunol, Immunology, Immunology today, Influenza, Ligand, Lymphocyte, Lytic, Lytic activity, Mabs, Melanoma cells, Mltc, Natural ligands, Phenotype, Precursor cells, Receptor, Soluble factors, Stimulator cells, Target cells, Tumour.
Abstract
Abstract: The receptors involved in apparently nonspecific, MHC- unrestricted effector cell-target cell interaction and lysis continue to raise controversy. They bind to distinct ligands on their target cells and activate diverse cellular functions such as gene expression, lymphokine production, proliferation and/or cytolytic activity by the effector cells. Several distinct receptors may mediate MHC-unrestricted cytotoxicity. Here, Peter Hersey and Reinder Bolhuis review evidence that the four main receptors involved in triggering this form of lytic activity are the CD2 molecule (the sheep red cell receptor), CD3-associated αβ chain T-cell receptor (TCR), the γδ chain TCR-CD3 complex and the CD16 molecule (the IgG0Fc receptor). The apparent non-specificity specificity of killing is a reflection of the widespread expression of natural ligands for these receptors on target cells.
Url:
DOI: 10.1016/0167-5699(87)90173-3
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001603
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :001603
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000F86
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :002396
Links to Exploration step
ISTEX:11C50A6DEE337A22EA7002394F1BAE26472DE9BDLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>‘Nonspecific’ MHC-unrestricted killer cells and their receptors</title>
<author><name sortKey="Hersey, Peter" sort="Hersey, Peter" uniqKey="Hersey P" first="Peter" last="Hersey">Peter Hersey</name>
</author>
<author><name sortKey="Bolhuis, Reinder" sort="Bolhuis, Reinder" uniqKey="Bolhuis R" first="Reinder" last="Bolhuis">Reinder Bolhuis</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:11C50A6DEE337A22EA7002394F1BAE26472DE9BD</idno>
<date when="1987" year="1987">1987</date>
<idno type="doi">10.1016/0167-5699(87)90173-3</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-0ZRV3G8N-1/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001603</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001603</idno>
<idno type="wicri:Area/Istex/Curation">001603</idno>
<idno type="wicri:Area/Istex/Checkpoint">000F86</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000F86</idno>
<idno type="wicri:doubleKey">0167-5699:1987:Hersey P:nonspecific:mhc:unrestricted</idno>
<idno type="wicri:Area/Main/Merge">002396</idno>
<idno type="wicri:Area/Main/Curation">002285</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">‘Nonspecific’ MHC-unrestricted killer cells and their receptors</title>
<author><name sortKey="Hersey, Peter" sort="Hersey, Peter" uniqKey="Hersey P" first="Peter" last="Hersey">Peter Hersey</name>
<affiliation wicri:level="1"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Immunology and Oncology Unit, David Maddison Clinical Sciences Building, Royal Newcastle Hospital, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bolhuis, Reinder" sort="Bolhuis, Reinder" uniqKey="Bolhuis R" first="Reinder" last="Bolhuis">Reinder Bolhuis</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Immunology, Rotterdam Radio-Therapeutic Institute and The Dr Daniel den Hoed Cancer Center, Rotterdam</wicri:regionArea>
<placeName><settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Immunology Today</title>
<title level="j" type="abbrev">IMTO</title>
<idno type="ISSN">0167-5699</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1987">1987</date>
<biblScope unit="volume">8</biblScope>
<biblScope unit="issue">7–8</biblScope>
<biblScope unit="page" from="233">233</biblScope>
<biblScope unit="page" to="239">239</biblScope>
</imprint>
<idno type="ISSN">0167-5699</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0167-5699</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Aiio</term>
<term>Autol</term>
<term>Autol aiio</term>
<term>Autologous tumour cells</term>
<term>Bolhuis</term>
<term>Cell growth</term>
<term>Cell surface</term>
<term>Clone</term>
<term>Conjugate formation</term>
<term>Cytotoxic</term>
<term>Cytotoxic activity</term>
<term>Cytotoxicity</term>
<term>Determinant</term>
<term>Effector</term>
<term>Effector cells</term>
<term>Etal</term>
<term>Griend</term>
<term>Immunol</term>
<term>Immunology</term>
<term>Immunology today</term>
<term>Influenza</term>
<term>Ligand</term>
<term>Lymphocyte</term>
<term>Lytic</term>
<term>Lytic activity</term>
<term>Mabs</term>
<term>Melanoma cells</term>
<term>Mltc</term>
<term>Natural ligands</term>
<term>Phenotype</term>
<term>Precursor cells</term>
<term>Receptor</term>
<term>Soluble factors</term>
<term>Stimulator cells</term>
<term>Target cells</term>
<term>Tumour</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: The receptors involved in apparently nonspecific, MHC- unrestricted effector cell-target cell interaction and lysis continue to raise controversy. They bind to distinct ligands on their target cells and activate diverse cellular functions such as gene expression, lymphokine production, proliferation and/or cytolytic activity by the effector cells. Several distinct receptors may mediate MHC-unrestricted cytotoxicity. Here, Peter Hersey and Reinder Bolhuis review evidence that the four main receptors involved in triggering this form of lytic activity are the CD2 molecule (the sheep red cell receptor), CD3-associated αβ chain T-cell receptor (TCR), the γδ chain TCR-CD3 complex and the CD16 molecule (the IgG0Fc receptor). The apparent non-specificity specificity of killing is a reflection of the widespread expression of natural ligands for these receptors on target cells.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002285 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 002285 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:11C50A6DEE337A22EA7002394F1BAE26472DE9BD |texte= ‘Nonspecific’ MHC-unrestricted killer cells and their receptors }}
This area was generated with Dilib version V0.6.33. |